Federal Data Hub › HRSA 340B · JSON
340B ID DSH080003
ParticipatingDisproportionate Share Hospital
ST FRANCIS HOSPITAL, INC is a Disproportionate Share Hospital enrolled in the federal 340B Drug Pricing Program in WILMINGTON, DE. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 17 contract-pharmacy arrangement(s) (1 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| ECKERD CORPORATION | NEW CASTLE, DE | 2019-01-01 | 2020-10-09 | 26440 |
| ECKERD CORPORATION | WILMINGTON, DE | 2019-01-01 | 2019-04-09 | 26498 |
| ECKERD CORPORATION | WILMINGTON, DE | 2016-04-01 | 2017-01-17 | 26497 |
| GREENHILL SPECIALTY PHARMACY LLC. | WILMINGTON, DE | 2019-07-01 | 2020-07-15 | 118816 |
| IVIRA PHARMACY | WILMINGTON, DE | 2019-07-01 | 2020-07-15 | 109456 |
| OPTION CARE ENTERPRISES, INC. | NEWARK, DE | 2019-07-01 | 2020-07-15 | 26416 |
| OPTION CARE ENTERPRISES, INC. | LOUISVILLE, KY | 2020-04-01 | 2020-07-15 | 47397 |
| RITE AID OF DELAWARE, INC. | NEW CASTLE, DE | 2016-04-01 | 2023-08-31 | 26441 |
| RITE AID OF DELAWARE, INC. | WILMINGTON, DE | 2016-04-01 | 2020-10-09 | 26476 |
| RITE AID OF DELAWARE, INC. | WILMINGTON, DE | 2016-04-01 | 2023-08-31 | 26461 |
| RITE AID OF DELAWARE, INC. | WILMINGTON, DE | 2016-04-01 | 2023-08-31 | 26464 |
| RITE AID OF DELAWARE, INC. | WILMINGTON, DE | 2019-01-01 | 2019-04-09 | 26507 |
| RITE AID OF DELAWARE, INC. | WILMINGTON, DE | 2016-04-01 | 2023-08-31 | 26506 |
| SHAYONA HEALTH INC. | WILMINGTON, DE | 2019-07-01 | 2023-09-08 | 99876 |
| SYNERGY RX EXPRESS PHARMACY | NEW CASTLE, DE | 2019-01-01 | 2020-10-09 | 111557 |
| TRINITY HEALTH PHARMACY SERVICES, LLC | FORT WAYNE, IN | 2021-10-01 | — | 125007 |
| UNIONCARE PHARMACY | WILMINGTON, DE | 2018-01-01 | 2018-10-10 | 104875 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.